Local Recurrence of Rectal Cancer After Transanal Total Mesorectal Excision and Risk Factors: A Nationwide Multicenter Cohort Study in Japan

• Published in: Annals of surgery open 2024-03, Vol.5 (1), p.e369-e369
• Main Authors: Matsuda, Takeru, Takemasa, Ichiro, Endo, Hideki, Mori, Shinichiro, Hasegawa, Suguru, Hida, Koya, Tokunaga, Takuya, Tanaka, Keitaro, Mukai, Toshiki, Watanabe, Jun, Kawamura, Junichiro, Kimura, Kei, Kakeji, Yoshihiro, Watanabe, Masahiko, Yamamoto, Seiichiro, Naitoh, Takeshi
• Format: Article
• Language: English
• Subjects: Original Study
• ISSN: 2691-3593; 2691-3593
• DOI: 10.1097/AS9.0000000000000369

To investigate the oncological outcomes after transanal total mesorectal excision (TaTME) for rectal cancer and risk factors for local recurrence (LR). A high LR rate with a multifocal pattern early after TaTME has been reported in Norway and the Netherlands, causing controversy over the oncological safety of this technique. Twenty-six member institutions of the Japan Society of Laparoscopic Colorectal Surgery participated in this retrospective cohort study. A total of 706 patients with primary rectal cancer who underwent TaTME between January 2012 and December 2019 were included for analysis. The primary endpoint was the cumulative 3-year LR rate. A total of 253 patients had clinical stage III disease (35.8%) and 91 (12.9%) had stage IV. Intersphincteric resection was performed in 318 patients (45.0%) and abdominoperineal resection in 193 (27.3%). There was 1 urethral injury (0.1%). A positive resection margin (R1) was seen in 42 patients (5.9%). Median follow-up was 3.42 years, and the 2- and 3-year cumulative LR rates were 4.95% (95% confidence interval: 3.50-6.75) and 6.82% (95% confidence interval: 5.08-8.89), respectively. A multifocal pattern was observed in 14 (25%) of 56 patients with LR. Tumor height from the anal verge, pathological T4 disease, pathological stage III/IV, positive perineural invasion, and R1 resection were significant risk factors for LR in multivariable analysis. In this selected cohort in which intersphincteric resection or abdominoperineal resection was performed in more than half of cases, oncological outcomes were acceptable during a median follow-up of more than 3 years.